About Putative sodium/bile acid cotransporter 4
Putative sodium/bile acid cotransporter 4 (SLC10A4) is a protein
from Homo sapiens identified by UniProt accession
Q96EP9, 437 residues long.
MolForge cross-references it against 0 known binders and
99 disease associations.
Target properties
| Protein name | Putative sodium/bile acid cotransporter 4 |
| UniProt accession | Q96EP9 |
| Gene | SLC10A4 |
| Organism | Homo sapiens |
| Length | 437 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (99)
Diseases linked to this target (Open Targets).
- body height · score 0.15
- hematocrit · score 0.14
- hemoglobin measurement · score 0.14
- age at menopause · score 0.11
- systolic blood pressure · score 0.11
- cortical surface area measurement · score 0.11
- X-linked non-syndromic intellectual disability · score 0.10
- pulse pressure measurement · score 0.09
- sitting height measurement · score 0.09
- brain measurement · score 0.09
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96EP9-F1 | alphafold | PREDICTED | 70.87 | — |
Amino-acid sequence (437 residues)
MDGNDNVTLL FAPLLRDNYT LAPNASSLGP GTDLALAPAS SAGPGPGLSL GPGPSFGFSP GPTPTPEPTT SGLAGGAASH GPSPFPRPWA PHALPFWDTP LNHGLNVFVG AALCITMLGL GCTVDVNHFG AHVRRPVGAL LAALCQFGLL PLLAFLLALA FKLDEVAAVA VLLCGCCPGG NLSNLMSLLV DGDMNLSIIM TISSTLLALV LMPLCLWIYS WAWINTPIVQ LLPLGTVTLT LCSTLIPIGL GVFIRYKYSR VADYIVKVSL WSLLVTLVVL FIMTGTMLGP ELLASIPAAV YVIAIFMPLA GYASGYGLAT LFHLPPNCKR TVCLETGSQN VQLCTAILKL AFPPQFIGSM YMFPLLYALF QSAEAGIFVL IYKMYGSEML HKRDPLDEDE DTDISYKKLK EEEMADTSYG TVKAENIIMM ETAQTSL
Explore Putative sodium/bile acid cotransporter 4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets